Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Toxicity × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 5863 Pancreatic Neoplasms 3512 Carcinoma, Hepatocellular 3230 Stomach Neoplasms 3016 Colonic Neoplasms 2316 Rectal Neoplasms 2173 Esophageal Neoplasms 1785 Liver Neoplasms 1237 Neoplasms 1173 Breast Neoplasms 1052 Neoplasm Metastasis 859 Carcinoma, Non-Small-Cell Lung 778 Lung Neoplasms 736 Cholangiocarcinoma 727 Gastrointestinal Neoplasms 649 Ovarian Neoplasms 622 Esophageal Squamous Cell Carcinoma 572 Prostatic Neoplasms 482 Melanoma 455 Biliary Tract Neoplasms 430 Head and Neck Neoplasms 371 Uterine Cervical Neoplasms 340 Carcinoma, Renal Cell 325 Gastrointestinal Stromal Tumors 319 Adenocarcinoma Of Esophagus 312 Sarcoma 302 Barrett Esophagus 300 Anus Neoplasms 281 Urinary Bladder Neoplasms 280 Gallbladder Neoplasms 279

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351089 2020-03-05

ProRad

Probi AB

Phase NA Terminated

GastrointestinalGynecologic

Gastrointestinal Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡